ANUH PHARMA
|
The Current P/E Ratio of ANUH PHARMA is 19.13.
| Share Price | ₹78.4 | Jun 25,2026 |
| Market Cap | ₹785.4 Cr | |
| Earnings-TTM | ₹41.0 Cr | TTM-Standalone Results |
| Price/Earnings | 19.13x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ANUH PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹785.4 Cr] as on Jun 25,2026
(/) Earnings [ ₹41.0 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 19.13x ]
Thus, for ANUH PHARMA , the investors are currently willing to pay 19.13 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ANUH PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ANUH PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of ANUH PHARMA
PE Ratio Performance Analysis for ANUH PHARMA
- ANUH PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.83x.
- ANUH PHARMA 's operated at median p/e ratio of 11.03x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ANUH PHARMA 's p/e ratio peaked in Mar2021 at 15.91x.
- ANUH PHARMA 's p/e ratio hit its five-year low in Mar2025 of 7.88x.
How does ANUH PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ANUH PHARMA | 41.05 | 19.13 | 785.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.63 | 446,792.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 69.37 | 178,152.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 71.52 | 152,915.0 |
| CIPLA LTD | 3,869.79 | 30.07 | 116,354.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 27.19 | 112,681.0 |
| MANKIND PHARMA LTD | 1,926.41 | 52.76 | 101,632.0 |
| LUPIN LTD | 5,355.47 | 20.00 | 107,091.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.86 | 109,875.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.55 | 89,468.4 |
| LAURUS LABS LTD | 889.85 | 88.07 | 78,368.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ANUH PHARMA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 19.13x |
| Max industry PE | 88.07x |
| Median industry PE | 30.07x |
| Average industry PE | 42.20x |
You may also like the below Video Courses